| インド | トルコ | オーストリア | |
| 大腸癌に対する放射線療法 | から $3,200 | から $7,000 | から $12,000 |
| 乳癌化学療法 | から $3,500 | から $1,200 | から $15,000 |
Bookimedは肝癌ステージ2治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。肝癌ステージ2治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。肝癌ステージ2治療の旅路でお一人になることはありません。
この医師は、高度な技術を持つ腫瘍専門医であり、固形腫瘍、小児腫瘍、血液悪性腫瘍を含むさまざまな癌の治療を専門としています。彼女は、ウィップル手術などの保守的および外科的治療の両方に精通しています。<\/p>
彼女はLady Hardinge Medical CollegeでMBBSを取得し、Maulana Azad Medical Collegeで内科のMDを取得しました。その後、Tata Memorial HospitalでDM医療腫瘍学を追求し、そこでコンサルタントとしても勤務しました。<\/p>
彼女は国際的および国内の腫瘍学会に所属しており、肺、乳房、婦人科、泌尿生殖器の癌に関する専門知識を持ち、免疫療法とメトロノミック療法に特に関心を持っています。<\/p>
医師はShyam Shah Medical Collegeで内科の医学博士号を取得し、同部門でシニアレジデンシーを務めました。その後、Jawaharlal Nehru Cancer Hospitalで医療腫瘍学のレジストラとして勤務しました。医師はIndraprastha Apollo Hospitalで医療腫瘍学のDNBトレーニングを修了しました。
シニアレジデンシーの期間中、医師はAIIMSで開催されたInternational Winter School of Oncologyで講義を行い、American Society of Clinical OncologyによるGastrointestinal Cancer Symposiumで胃がんに関する研究を発表しました。医師はがんの分子基盤と標的療法を専門としています。
この医師は、HCG Manavata Cancer Centreで12年間の経験を持つ熟練した核医学専門医です。医師は、さまざまな核スキャン、PET-CTスキャン、および核心臓病学サービスを専門としており、放射性ヨウ素およびLu-177 RN療法において熟練しています。キャリアの中で、医師は30,000件以上のPETスキャンを管理し、1,000人以上の甲状腺癌患者を治療してきました。さらに、医師はさまざまな医学雑誌に論文を発表することで、この分野に貢献しています。
Stage 2 liver cancer is curable when the disease remains localized. Leading Indian centers achieve curative outcomes through surgical resection, liver transplantation, or thermal ablation. Success depends on liver function, tumor size, and the absence of vascular invasion or distant spread.
Bookimed Expert Insight: India has become a global leader in living donor liver transplants (LDLT). Global Hospital Chennai has performed over 1,000 successful transplants. While transplant is often the most definitive cure, our data shows that high-volume centers like HCG Manavata treat over 75,000 patients annually. This suggests that for many, sophisticated surgical resection or integrated oncological care is the more accessible curative path before considering a transplant.
Patient Consensus: Patients emphasize that a stage 2 diagnosis is only the starting point. Many note it is vital to confirm if a tumor is truly resectable by a hepatobiliary specialist before starting other therapies. They often recommend seeking a second opinion at a dedicated liver institute to ensure no time is lost on non-curative treatments.
India provides highly advanced minimally invasive alternatives for liver cancer patients unfit for major surgery. Leading centers utilize interventional radiology and robotic systems. These technologies allow for localized tumor destruction without large abdominal incisions. They significantly reduce physical trauma and recovery time.
Bookimed Expert Insight: Patient data shows Global Hospital Chennai is a standout for complex liver cases. It has performed over 1,000 successful liver transplants. This high volume often translates to expertise in non-surgical alternatives like robotic-assisted procedures. Choosing such a high-capacity center ensures access to the most precise linear accelerators available.
Patient Consensus: Patients note that being unfit for surgery does not mean options are exhausted. Many find relief through locoregional treatments like RFA which involve less pain and faster healing.
India features high-volume liver centers recognized by Newsweek and JCI for managing stage 2 hepatobiliary oncology. Leading hospitals include Global Hospital Chennai, which has performed over 1,000 liver transplants. Medanta and Apollo Delhi offer complex resections and advanced interventional radiology for vascular tumors.
Bookimed Expert Insight: Patients often focus on city location, but hospital volume is a more reliable quality indicator. For instance, Global Hospital Chennai and Apollo Hospital Delhi each serve over 1,000,000 patients annually. These high-volume centers typically maintain larger multidisciplinary tumor boards, which is essential when deciding between resection and transplant for stage 2 cases.
Patient Consensus: Patients emphasize the need for a dedicated hepatobiliary surgeon and a multidisciplinary tumor board rather than just a famous hospital name. Many recommend visiting tertiary centers like Tata Memorial for second opinions on surgical resectability before finalizing treatment.
Indian liver transplants primarily utilize living donors due to limited deceased donor availability. Healthy individuals between 18 and 55 with compatible blood types can donate a portion of their liver. Under the Transplantation of Human Organs Act, the liver naturally regenerates to full size within weeks.
Bookimed Expert Insight: India hosts massive transplant networks, with Apollo Hospital Indraprastha recognized as one of the largest centers in Asia. Global Hospital Chennai has successfully performed over 1,000 liver transplants. This high volume allows centers like Dr. Rela Institute to perform complex surgeries, including record-breaking pediatric cases, using advanced robotic systems.
Patient Consensus: Patients emphasize that being a willing donor is not enough. You must pass strict tests for fatty liver and blood compatibility before the legal committee even considers your case.
Stage 2 liver cancer patients in India can expect a 5-year survival rate between 35% and 37% on average. However, successful surgical outcomes significantly improve these odds. Liver transplant recipients often see 60% to 80% survival, while surgical resection outcomes typically range from 54% to 70%.
Bookimed Expert Insight: India excels in high-volume transplant surgery, which directly impacts long-term survival. Global Hospital Chennai has performed over 1,000 liver transplants. Dr. Mohamed Rela at Rela Institute holds a world record for pediatric transplant. Choosing such high-volume centers often ensures access to standardized post-surgical protocols that improve long-term outcomes.
Patient Consensus: Patients emphasize that success depends on truly curative surgery rather than temporary control. They note that survival feels more secure when underlying conditions like cirrhosis or hepatitis are managed alongside the cancer.
Indian health insurance covers liver cancer treatments like resection, ablation, TACE, and transplants. Standard indemnity plans and critical illness policies typically include these procedures. Approval depends on waiting periods, pre-existing condition clauses, and whether the hospital is JCI or NABH accredited.
Bookimed Expert Insight: High-volume centers like Global Hospital Chennai, which has performed over 1,000 liver transplants, often have specialized teams to handle insurance documentation. Selecting a facility with multiple accreditations like NABH and JCI can streamline the cashless approval process for complex Stage 2 oncology cases. This expertise reduces the likelihood of administrative claim denials for advanced procedures like TACE or ablation.
Patient Consensus: Patients note that while major surgeries are easier to claim, items like ICU consumables and imported drugs often require significant out-of-pocket payments. Pre-authorization is essential as cashless approval is never guaranteed, even in large hospital networks.
Minimizing liver cancer recurrence requires diligent medical surveillance and lifestyle management to protect liver health. Patients should prioritize regular imaging scans and alpha-fetoprotein blood tests. Managing underlying conditions like hepatitis or cirrhosis is vital. Maintaining a plant-forward diet and avoiding alcohol helps preserve liver function.
Bookimed Expert Insight: India’s leading oncology centers like HCG Manavata and Apollo Hospital Indraprastha emphasize a multi-disciplinary follow-up approach. While many focus on surgery, our data shows top specialists like Dr. Raj Nagarkar have performed over 50,000 surgeries. This high volume highlights that long-term success depends on matching surgical skill with strict post-operative monitoring. Centers like Dr. Rela Institute use linear accelerators with 1 mm accuracy. Specialized technology helps target recurrences early when they are most treatable.
Patient Consensus: Patients emphasize that staying on top of scheduled imaging is the most important guard against silent recurrence. Many survivors note that managing diabetes and metabolic health was also a surprisingly critical factor in their recovery.